SR One Investors
SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested approximately 800 million in more than 180 companies.
Invests into
%20.jpg)
Headquarters:
United States
Founded Date:
1985
Investor Type:
Venture Capital
Number Of Exists:
53
Employee Number:
1-10